Genmab — Maj 2018
-
Der er et par interessante kommentarer til denne artikel http://www.myelomabeacon.com/news/2018/04/30/shorter-darzalex-infusion-times/
-
-
Nej ikke det store. Det var ventet, og denne kombi bruges vist ikke ret meget i USA
-
Og så lige igen i Børsen

-
-
Tak Plimsoller. Så venter vi på Maia https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=480069013&sourcecode=ddk
-
Godkendelsen i første linie giver måske ikke så meget på bundlinjen, men det understøtter da bestemt at processen kører efter en snor. Supergodt arbejde.
-
Angående Bull certifikater fra SEB - så opdateres denne dagligt: https://seb.dk/certifikater/borsnoterede-certifikater/kursliste-certifikater
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
(daratumumab) i nydiagnostiseret multipel myelom